🇺🇸 FDA
Patent

US 11858932

Methods and compositions for treating polycystic ovary syndrome

granted A61KA61K31/426A61K31/437

Quick answer

US patent 11858932 (Methods and compositions for treating polycystic ovary syndrome) held by SPRUCE BIOSCIENCES, INC. expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SPRUCE BIOSCIENCES, INC.
Grant date
Tue Jan 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/426, A61K31/437, A61K31/44, A61K31/4965